Anti-C6orf89 antibody [EPR13621]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal C6orf89 antibody. Suitable for WB and reacts with Human samples. Cited in 4 publications.
View Alternative Names
BRAP, UNQ177/PRO203, C6orf89, Bombesin receptor-activated protein C6orf89, Amfion
- WB
Supplier Data
Western blot - Anti-C6orf89 antibody [EPR13621] (AB181073)
All lanes:
Western blot - Anti-C6orf89 antibody [EPR13621] (ab181073) at 1/1000 dilution
Lane 1:
A549 cell lysate at 20 µg
Lane 2:
293 cell lysate at 20 µg
Lane 3:
HepG2 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 40 kDa
false
Related conjugates and formulations (1)
-
Anti-C6orf89 antibody [EPR13621] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The role of C6orf89 remains largely ambiguous but researchers believe it may have links to cellular metabolism and regulatory processes. Currently there is no direct evidence suggesting that C6orf89 is part of a larger protein complex. More research is needed to uncover its specific biological functions and interactions with other molecular structures in the cell.
Pathways
Scientists have yet to allocate a precise pathway where C6orf89 functions prominently. It is essential to explore how it interacts with known cellular pathways such as the metabolic pathways or regulatory networks to understand its contribution better. Other proteins potentially like AMPK or mTOR signaling components might interact with it once its exact mechanistic role becomes clearer.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Clinical and experimental pharmacology & physiology 51:e13916 PubMed39155151
2024
Applications
Unspecified application
Species
Unspecified reactive species
FEBS letters 597:2626-2642 PubMed37715941
2023
Applications
Unspecified application
Species
Unspecified reactive species
Life science alliance 5: PubMed35820707
2022
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 5: PubMed32897879
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com